Human skull symbolism

Novarad's VisAR System Demonstrates High Accuracy for EVD Placement

Retrieved on: 
Wednesday, January 18, 2023
EVD, Ballistic gelatin, SALT, University, Human skull symbolism, Learning curve, VISAR, Surgeon, FDA, AR, Ventriculostomy, Assistant, Microsoft, Workflow, Physician, Medical device, Surveying, Neurosurgery

Novarad's VisAR Augmented Reality Surgical Navigation gets robotic accuracy with EVD placement,

Key Points: 
  • Novarad's VisAR Augmented Reality Surgical Navigation gets robotic accuracy with EVD placement,
    While EVD is a common neurosurgical procedure, it hasn't changed much in 100 years.
  • To evaluate Novarad's VisAR system for its potential to improve the accuracy of EVD placement, researchers constructed phantom models: a skull phantom model filled with ballistic gelatin and a phantom model simulating the ventricular structure.
  • In addition, the ability of VisAR flattening the learning curve and improving accuracy of surgeons of various levels of training was studied in a cadaver model.
  • The measured accuracy was done using VisAR on both phantom and cadaver models.

ENT Care Centers Advances Ear, Nose, and Throat Care In the Louisville Region By Uniting Quality Providers Under One Trusted Name

Retrieved on: 
Tuesday, December 13, 2022
Audiology, Community, Tonsillectomy, Health, Patient, Human skull symbolism, Nose, Otorhinolaryngology, Kool-Aid, Sleep apnea, Adenoidectomy, Ear, PLLC, Hearing, ENT, Hospital, Dentistry, Greater Louisville Inc.

LOUISVILLE, Ky., Dec. 13, 2022 /PRNewswire-PRWeb/ -- ENT Care Centers, PLLC is leading the way for quality ear, nose, and throat care in the Louisville area with its collaborative approach to industry innovation and patient care. The newly formed medical practice aggregation combines four of the Louisville area's top otolaryngologic providers Kentuckiana ENT, ENT Associates, Community ENT, and Louisville ENT under one umbrella and mission, all committed to offering a better continuum of care and enhancing patient outcomes.

Key Points: 
  • LOUISVILLE, Ky., Dec. 13, 2022 /PRNewswire-PRWeb/ -- ENT Care Centers, PLLC is leading the way for quality ear, nose, and throat care in the Louisville area with its collaborative approach to industry innovation and patient care.
  • "ENT Care Centers is proud to serve as a hub for medical innovation and the gold standard for otolaryngologic care throughout the Louisville area and Southern Indiana," said Dr. Thomas Higgins, ENT Care Centers president and chairman of the board.
  • To learn more about ENT Care Centers and its locations across the Greater Louisville region and Southern Indiana, visit https://www.entcarecenters.com/.
  • ENT Care Centers is the collaborative effort of four ENT practices in Louisville, KY and Jeffersonville, INKentuckiana ENT, Louisville Family ENT, Community ENT, and ENT Associates.

First SyncAR for Spine Surgery in the World Performed at Hoag

Retrieved on: 
Wednesday, December 7, 2022
Magnet, Hoag (health network), Patient, Physician, Heart, Culture, Asa, CT, AR, OC, American Nurses Credentialing Center, Spine, ANCC, Anatomy, MRI, Cancer, Neuroscience, AFI's 10 Top 10, X-ray, Hospital, Neurosurgery, FDA, 3D, Robotics, News, Surgeon, Pathology, Multimedia, Health, UPMC, Elective surgery, Pharmaceutical industry, Medicine, Human skull symbolism

NEWPORT BEACH, Calif., Dec. 7, 2022 /PRNewswire/ -- Hoag's innovative spine team has performed the first spinal fusion surgery utilizing the recently FDA-cleared augmented reality (SyncAR) surgical navigator for Spine, co-developed by neurosurgeons from Hoag's Pickup Family Neurosciences Institute and medical visualization platform leader Surgical Theater.

Key Points: 
  • SyncAR for Spine utiizes 3D virtual reconstructions of CT and MRI images to enable detailed visualization of anatomic structures as well as the surgical tools and hardware.
  • Hoag's neurosurgeons have already studied and published the benefits of SyncAR technology in the lab, demonstrating an improved accuracy of >99% for screw placement in the spine.
  • SyncAR for Spine subsequently received FDA clearance in September 2022 paving the way for its utilization in the operating room to help real people.
  • "SyncAR for Spine is allowing not only enhanced navigation in the operating room, it is enabling more enlightening and informed pre-operative conversations with our patients.

Rethink Your Workout: Q4 Active Launches Proprietary Boutique Fitness Studio

Retrieved on: 
Monday, November 14, 2022
Health, Dementia, Heart, Population, Environment, Warner Center, Los Angeles, MacEwen, Entrepreneurship, Ageing, Program, Human skull symbolism, CEO, Q4, Life, Brain, Longevity, Exercise, Toy, Mobile phone, Medical device

LOS ANGELES, Nov. 14, 2022 /PRNewswire/ -- Q4 Active, a fitness studio dedicated to individuals 50+ will open December 1 in Woodland Hills, a suburb of Los Angeles, California. An entirely new fitness concept, Q4 Active supports physical and brain performance in a welcoming, engaging, and energizing environment.

Key Points: 
  • An entirely new fitness concept, Q4 Active supports physical and brain performance in a welcoming, engaging, and energizing environment.
  • Conveniently located in the heart of Warner Center in Woodland Hills, Q4 Active boutique fitness studio members will enjoy fun, fulfilling body and brain exercise.
  • Q4 Active's proprietary fitness programming is designed to improve cognitive health and functional longevity for happier, healthier lives.
  • Q4 Active houses two separate exercise studios that deliver the proprietary Q4 Active brain and body circuit, as well as more specialized programming including small-group, 12-week cognitive fitness programs, personal training, post-rehabilitation training, nutrition workshops, invited speakers, and other social events.

Unique Partnership Seeks to Advance Precision Medicine Options for Deadly GBM Brain Tumors

Retrieved on: 
Monday, October 10, 2022
News, LinkedIn, Human skull symbolism, Time, GBM, Precision medicine, Automation, Neoplasm, Drug development, Patient, 3D, MIPS, APS, Publication, Twitter, HIV disease progression rates, Oncology, RNA, Glioma, Partnership, Cancer, Tumor microenvironment, Doctor of Philosophy, CEO, Neurosurgery, Health, Patent, Breast, NICO, Glioblastoma, Pearson, Neuro, Medical imaging

INDIANAPOLIS, Oct. 10, 2022 /PRNewswire/ -- The ability to optimize precision medicine therapies for patients fighting aggressive and deadly brain cancers like Glioblastoma Multiforme (GBM) starts with quality tissue specimens with molecular integrity intact. Improvements in tissue quality can then fuel improved outcomes through patient-specific predictive response to therapies.

Key Points: 
  • Precision medicine for GBM patients starts with quality tissue to achieve patient-specific predictive response therapy.
  • NICO's automated, non-ablative and non-thermal Myriadtissue resection device and Automated Preservation System(APS) collects and biologically preserves tissue while in the operating suite.
  • This helps maintain the tumor microenvironment, which aids in the preservation of biological information needed for researchers and clinicians.
  • "This partnership is a step in the right direction for dramatically increasing the percentage of patients we can help with precision medicine."

Daniel M. Prevedello, MD, MBA, FACS, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, September 6, 2022
EEA, Nervous system, University, FACS, Spine, Mentorship, Continental, Paranasal sinuses, Disorder, Congress of Neurological Surgeons, OH, American Board of Commissioners for Foreign Missions, Skull, Human skull symbolism, Brain, Peripheral nervous system, Nose, Ohio State University, Music, Head, Rehabilitation, Neurosurgery, Board, Executive, Diagnosis, The James Cancer Hospital, Stroke, Infection, Spinal cord injury, Fellowship of the Royal Colleges of Surgeons, Virgin Islands, MBA, Medicine, Surgeon, Patient, Neoplasm, Ohio State University Wexner Medical Center, Association, Spinal cord, American Association of Neurological Surgeons, Director, Congress, CNS, Family, American College, American Association, Dentistry, MD

With over 20 years of experience in medicine, Dr. Prevedello is a well-known neurosurgeon specializing in skull base pathologies and brain tumors.

Key Points: 
  • With over 20 years of experience in medicine, Dr. Prevedello is a well-known neurosurgeon specializing in skull base pathologies and brain tumors.
  • Likewise, he remains affiliated with The James Cancer Hospital and Solove Research Institute, Ohio State Same-Day Immediate Care Outpatient Care Worthington, and OSU Wexner Medical Center.
  • He performs skull base surgery for all tumors and diseases of this body area.
  • Neurosurgeons are doctors who diagnose and treat problems with the nervous system, often by performing surgery on the brain or spine.

Prominent Neurosurgeon Joins Leucadia Therapeutics as Company's Founding Global Chief Medical Officer

Retrieved on: 
Monday, August 22, 2022
Western University, CEO, FACS, Research, Oxon, The Society of Neurological Surgeons, Therapy, SAN, Brain, FRCSC, Disease, Western University of Health Sciences, Outline of health sciences, CSF, Arrowhead Regional Medical Center, Torney General Hospital, Human skull symbolism, Siddiqui, Riverside University Health System Medical Center, Alzheimer's disease, Leadership, University of Oxford, Association, Institute, Cerebrospinal fluid, California University, Medical imaging, Medical device, Pharmaceutical industry, Neurosurgery, MD, Neurology

SAN DIEGO, Aug. 22, 2022 /PRNewswire/ -- Leucadia Therapeutics, a company working to cure Alzheimer's disease, has hired a global chief medical officer practiced in skull base neurosurgery needed to implant the company's revolutionary Arethusta® device, which drains disease-causing toxins from the brain.

Key Points: 
  • Widely regarded as an innovator, Siddiqi brings more than 21 years of surgical, administrative, academic, and leadership experience to Leucadia.
  • In addition to founding the Desert Regional Medical Center's Institute of Clinical Orthopedics & Neuroscience in Palm Springs, California, he leads the Neurosurgery programs at Arrowhead Regional Medical Center and Riverside University Health System Medical Center.
  • He is founding Editor-in-chief of the medical journal "Contemporary Reviews in Neurology and Neurosurgery."
  • Leucadia Therapeutics is a pre-clinical-stage company focused on diagnosing, treating and curing Alzheimer's disease.

Largest Study of Brain Tumor "Keyhole" Surgery for Meningiomas

Retrieved on: 
Thursday, August 4, 2022
Meningioma, Hospital, Risk, Radiosurgery, Endoscopy, Human skull symbolism, PNI, Brain, Myocardial infarction, Providence High School, Patient, Embolism, Publication, Cerebrospinal fluid leak, PLOS, Meningitis, MD, Saint John's Health Center, Blood, Neuro, Time, St. Mary's Medical Center (Grand Junction, Colorado), Cranial nerves, Medical imaging, Pharmaceutical industry

SANTA MONICA, Calif., Aug. 4, 2022 /PRNewswire/ -- In a groundbreaking 13-year study, Pacific Neuroscience Institute neurosurgical and otolaryngology surgical teams demonstrated outstanding outcomes with minimally invasive keyhole surgery for the most common primary brain tumor, in the largest such keyhole cohort published to date.

Key Points: 
  • "Patients coming to us with brain tumors are understandably worried about their diagnoses and clinical outcomes," said neurosurgeon Daniel Kelly, MD, PNI director and senior author of the study.
  • "Keyhole surgery aims to limit brain exposure and manipulation, using smaller strategically placed openings without the use of brain retractors and facilitated by gravity assistance and endoscopy.
  • Meningiomas, the most common primary brain tumor, are non-cancerous brain tumors estimated to be diagnosed in approximately 34,000 people in the United States each year.
  • From an overall cohort of 329 patients with meningiomas treated from 2008-21, the study focused on 193 (59%) who underwent 213 keyhole operations.

NICO Announces New Distributor for Australia and New Zealand Markets

Retrieved on: 
Wednesday, July 6, 2022
Automation, Neurosurgery, Surgeon, International, Adoption, Brain, Stroke, Awareness, Partnership, Therapy, Neoplasm, General manager, NICO, Patent, Human skull symbolism, Collection, Medical device

INDIANAPOLIS, July 6, 2022 /PRNewswire/ -- Medical device innovator NICO Corporationannounced that it has partnered with Imedcare , Australia-based supplier and distributor of devices specializing in neurosurgery for the Australia and New Zealand neurosurgery medical sector.

Key Points: 
  • INDIANAPOLIS, July 6, 2022 /PRNewswire/ -- Medical device innovator NICO Corporationannounced that it has partnered with Imedcare , Australia-based supplier and distributor of devices specializing in neurosurgery for the Australia and New Zealand neurosurgery medical sector.
  • NICO Corporation announces Imedcare as its distributor for Australia and New Zealand neurosurgery market.
  • "Their team has several years of experience in neurosurgery, which will further strengthen our product awareness and adoption in Australia and New Zealand and more importantly, offer surgeons the opportunity to positively affect patient outcomes."
  • Its technologies have been featured in more than 175 peer-reviewed published paperswith over 550 unique authors from major academic centers.

NICO Secures New Patent Approvals Supporting Neurosurgical Brain Access Solutions

Retrieved on: 
Friday, May 13, 2022
ENRICH, Neoplasm, Pearson, Patient, Human skull symbolism, Stroke, NICO, Neurosurgery, Patent, Brain, Automation, Therapy, Intracerebral hemorrhage, Collection, CEO, Medical imaging

Two new patents issued to NICO for its surgical access system, the system's assembly and method for use in brain surgery

Key Points: 
  • Two new patents issued to NICO for its surgical access system, the system's assembly and method for use in brain surgery
    "Protecting our intellectual property has always been a top priority for NICO," said Jim Pearson, president and CEO of NICO Corporation.
  • "Our technologies comprise an integrated systems approach to brain surgery that is creating new realities for neurosurgeons.
  • Pearson added that these two new patent approvals related to safe access to all regions of the brain are key to protecting the company's unique and revolutionary intellectual property.
  • NICO technologies have been featured in more than 170 peer-reviewed published papers with over 550 unique authors from major academic centers.